CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Gift CFO gave 16,000 shares (gift)
- 4 Shares withheld for taxes Chief Commercial Officer gave up 2,267 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,062 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 8,004 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 3,062 shares (to pay taxes)
- 4 Open-market buy CFO bought 10,000 shares at $2.85 ($28,500)
- 4 Shares withheld for taxes Chief Medical Officer gave up 11,439 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 11,438 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 27,618 shares (to pay taxes)
- 4 Open-market buy Director bought 5,650 shares at $1.69 ($9,549)
- 4 Open-market buy Chief Medical Officer bought 28,000 shares at $1.70 ($47,600)
- 4 Open-market buy CFO bought 45,000 shares at an average $1.77 ($79,578)
- 4 Open-market buy CEO bought 32,000 shares at $1.59 ($50,880)
- 4 Open-market buy Chief Commercial Officer bought 12,100 shares at an average $1.62 ($19,599)
- 4 Grant or award Chief Medical Officer acquired 123,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 32,000 shares (grant or award)
- 4 Grant or award CEO acquired 317,000 shares (grant or award)
- 4 Grant or award CFO acquired 107,000 shares (grant or award)
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 4 Grant or award Director acquired 21,000 shares (grant or award)
Page 1 of 11 · 208 filings